This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Gabriel Cheung, PhD
Senior Director, BioMedicine Design at Pfizer

Profile

Gabriel Cheung, Senior Director, BioMedicine Design, Medicinal Sciences, Worldwide Research and Development, Pfizer, Inc. Dr. Gabriel WC Cheung joined Pfizer in 2015. He is a Senior Director at BioMedicine Design. He oversees the endogenous antibody discovery, high throughput screening, and technologies group supporting Biotherapeutic needs across all Pfizer Research Units. Through his interests and passion in technology development and humoral immunity, Dr. Cheung is committed to transform how Pharma industry rapidly delivers high quality and functionally relevant biotherapeutics through the use of deep repertoire discovery. Prior to joining Pfizer, Dr. Cheung spent 14 years at Cell Signaling Technology leading the company to global leadership in rabbit monoclonal antibody development. He and his research team developed a number of industry leading and state-of-the-art antibody discovery technologies and platforms to address real world commercial needs. During his tenure at CST, he and his research team also made noticeable scientific contributions and collaborations in the field of immunology and vaccine leading to a number of patents and high profile publications in Nature Biotechnology, Nature Immunology, and Immunity. Dr. Cheung received his PhD in Biochemistry, molecular biology, and biophysics from University of Minnesota, Twin Cities.